Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer

被引：0
|
作者：
M F E Godinho
A M Sieuwerts
M P Look
D Meijer
J A Foekens
L C J Dorssers
T van Agthoven
机构：
[1] Josephine Nefkens Institute,Department of Pathology
[2] Erasmus MC-University Medical Center Rotterdam,Department of Medical Oncology
[3] Josephine Nefkens Institute,undefined
[4] Erasmus MC-University Medical Center Rotterdam,undefined
[5] Cancer Genomics Center,undefined
[6] Josephine Nefkens Institute,undefined
[7] Erasmus MC-University Medical Center Rotterdam,undefined
来源：
British Journal of Cancer | 2010年 / 103卷
关键词：
tamoxifen resistance; endocrine therapy; BCAR4; ERBB2; ERBB3; ERBB4;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1284 / 1291
页数：7
相关论文
共 50 条
  • [1] Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer
    Godinho, M. F. E.
    Sieuwerts, A. M.
    Look, M. P.
    Meijer, D.
    Foekens, J. A.
    Dorssers, L. C. J.
    van Agthoven, T.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 103 (08) : 1284 - 1291
  • [2] Relevance of BCAR4 in tamoxifen resistance and tumor aggressiveness of breast cancer
    Godinho, Marcia F. E.
    Sieuwerts, Anieta M.
    Look, Maxime P.
    Meijer, Danielle
    Sleijfer, Stefan
    Foekens, John A.
    Dorssers, Lambert C. J.
    van Agthoven, Ton
    [J]. CANCER RESEARCH, 2010, 70
  • [3] Relevance of BCAR4 in tamoxifen resistance and tumor aggressiveness of breast cancer
    Godinho, Marcia F. E.
    Sieuwerts, Anieta M.
    Look, Maxime P.
    Meijer, Danielle
    Sleijfer, Stefan
    Foekens, John A.
    Dorssers, Lambert C. J.
    van Agthoven, Ton
    [J]. CANCER RESEARCH, 2010, 70
  • [4] Characterization of BCAR4, a Novel Oncogene Causing Endocrine Resistance in Human Breast Cancer Cells
    Godinho, Marcia
    Meijer, Danielle
    Setyono-Han, Buddy
    Dorssers, Lambert C. J.
    van Agthoven, Ton
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2011, 226 (07) : 1741 - 1749
  • [5] BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
    M F E Godinho
    J D Wulfkuhle
    M P Look
    A M Sieuwerts
    S Sleijfer
    J A Foekens
    E F Petricoin
    L C J Dorssers
    T van Agthoven
    [J]. British Journal of Cancer, 2012, 107 : 947 - 955
  • [6] BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
    Godinho, M. F. E.
    Wulfkuhle, J. D.
    Look, M. P.
    Sieuwerts, A. M.
    Sleijfer, S.
    Foekens, J. A.
    Petricoin, E. F., III
    Dorssers, L. C. J.
    van Agthoven, T.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 107 (06) : 947 - 955
  • [7] BCAR4 Expression as a Predictive Biomarker for Endocrine Therapy Resistance in Breast Cancer
    Liao, Muheng
    Webster, Jace
    Coonrod, Emily M.
    Weilbaecher, Katherine N.
    Maher, Christopher A.
    White, Nicole M.
    [J]. CLINICAL BREAST CANCER, 2024, 24 (04)
  • [8] Variant in BCAR4 gene correlated with the breast cancer susceptibility and mRNA expression of lncRNA BCAR4 in Chinese Han population
    Peng, Rui
    Cao, Jingjing
    Guo, Qiaoyun
    Sun, Qiuyu
    Xu, Linping
    Xie, Xiaojuan
    Song, Chunhua
    [J]. BREAST CANCER, 2021, 28 (02) : 424 - 433
  • [9] Identification of signaling pathways activated by BCAR4 expression in human breast cancer
    Godinho, Marcia F. E.
    Wulfkuhle, Julia D.
    Petricoin, Emanuel F.
    Dorssers, Lambert C. J.
    van Agthoven, Ton
    [J]. CANCER RESEARCH, 2011, 71
  • [10] Breast cancer anti-estrogen resistance 4 (BCAR4) is a novel oncogene in lung cancer
    Bae, Kieun
    Lee, Minkyong
    Yoon, Daseul
    Kim, Yun-Hee
    Yoon, Kyong-Ah
    [J]. CANCER RESEARCH, 2017, 77
12345